Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway
The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.
Gespeichert in:
| Veröffentlicht in: | Investigational new drugs 2019-12, Vol.37 (6), p.1309-1309 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1309 |
|---|---|
| container_issue | 6 |
| container_start_page | 1309 |
| container_title | Investigational new drugs |
| container_volume | 37 |
| creator | Zhao, Piming Aguilar, Ana E. Lee, Joanna Y. Paul, Lucy A. Suh, Jung H. Puri, Latika Zhang, Meng Beckstead, Jennifer Witkowski, Andrzej Ryan, Robert O. Saba, Julie D. |
| description | The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics. |
| doi_str_mv | 10.1007/s10637-019-00772-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2216769860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2215984067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c215w-773c1b96eef564378cc2b6e83aff0895cd435372e73eec90af1f5358e396023a3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EokvhD3BAlrhwCfgjtmNu1arQqpV6aDlHjney6yprB9tptGf-eL1NAYkDJ2vGzzxj-UXoPSWfKSHqS6JEclURqqtSKlbNL9CKCsUrImv5Eq0IlaqSWqsT9Cale0II16p-jU44JZwJJlbo1zrECDa74HEOX_HtuHN-azYOPCScdmHGeQfRjDBlZzH0vbPGHrDz2MMUQzeYlMPeHBsPLseAjd8sxUPA3QFnE7eQi_PowWdXdzi5rTfDsTOavJvN4S161Zshwbvn8xT9-HZ-t76orm--X67PrivLqJgrpbilnZYAvZA1V421rJPQcNP3pNHCbmouuGKgOIDVxPS0F1w0wLUkjBt-ij4t3jGGnxOk3O5dsjAMxkOYUstY-S-pG0kK-vEf9D5MsTz7iRK6qYlUhWILZWNIKULfjtHtTTy0lLTHiNolorZE1D5F1M5l6MOzeur2sPkz8juTAvAFSOXKbyH-3f0f7SPSup4P</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2215984067</pqid></control><display><type>article</type><title>Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway</title><source>SpringerLink Journals</source><creator>Zhao, Piming ; Aguilar, Ana E. ; Lee, Joanna Y. ; Paul, Lucy A. ; Suh, Jung H. ; Puri, Latika ; Zhang, Meng ; Beckstead, Jennifer ; Witkowski, Andrzej ; Ryan, Robert O. ; Saba, Julie D.</creator><creatorcontrib>Zhao, Piming ; Aguilar, Ana E. ; Lee, Joanna Y. ; Paul, Lucy A. ; Suh, Jung H. ; Puri, Latika ; Zhang, Meng ; Beckstead, Jennifer ; Witkowski, Andrzej ; Ryan, Robert O. ; Saba, Julie D.</creatorcontrib><description>The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.</description><identifier>ISSN: 0167-6997</identifier><identifier>EISSN: 1573-0646</identifier><identifier>DOI: 10.1007/s10637-019-00772-w</identifier><identifier>PMID: 31032525</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>AKT protein ; Correction ; Medicine ; Medicine & Public Health ; Neuroblastoma ; Oncology ; Pharmacology/Toxicology ; Signal transduction</subject><ispartof>Investigational new drugs, 2019-12, Vol.37 (6), p.1309-1309</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Investigational New Drugs is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10637-019-00772-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10637-019-00772-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31032525$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Piming</creatorcontrib><creatorcontrib>Aguilar, Ana E.</creatorcontrib><creatorcontrib>Lee, Joanna Y.</creatorcontrib><creatorcontrib>Paul, Lucy A.</creatorcontrib><creatorcontrib>Suh, Jung H.</creatorcontrib><creatorcontrib>Puri, Latika</creatorcontrib><creatorcontrib>Zhang, Meng</creatorcontrib><creatorcontrib>Beckstead, Jennifer</creatorcontrib><creatorcontrib>Witkowski, Andrzej</creatorcontrib><creatorcontrib>Ryan, Robert O.</creatorcontrib><creatorcontrib>Saba, Julie D.</creatorcontrib><title>Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway</title><title>Investigational new drugs</title><addtitle>Invest New Drugs</addtitle><addtitle>Invest New Drugs</addtitle><description>The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.</description><subject>AKT protein</subject><subject>Correction</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neuroblastoma</subject><subject>Oncology</subject><subject>Pharmacology/Toxicology</subject><subject>Signal transduction</subject><issn>0167-6997</issn><issn>1573-0646</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9kU1v1DAQhi0EokvhD3BAlrhwCfgjtmNu1arQqpV6aDlHjney6yprB9tptGf-eL1NAYkDJ2vGzzxj-UXoPSWfKSHqS6JEclURqqtSKlbNL9CKCsUrImv5Eq0IlaqSWqsT9Cale0II16p-jU44JZwJJlbo1zrECDa74HEOX_HtuHN-azYOPCScdmHGeQfRjDBlZzH0vbPGHrDz2MMUQzeYlMPeHBsPLseAjd8sxUPA3QFnE7eQi_PowWdXdzi5rTfDsTOavJvN4S161Zshwbvn8xT9-HZ-t76orm--X67PrivLqJgrpbilnZYAvZA1V421rJPQcNP3pNHCbmouuGKgOIDVxPS0F1w0wLUkjBt-ij4t3jGGnxOk3O5dsjAMxkOYUstY-S-pG0kK-vEf9D5MsTz7iRK6qYlUhWILZWNIKULfjtHtTTy0lLTHiNolorZE1D5F1M5l6MOzeur2sPkz8juTAvAFSOXKbyH-3f0f7SPSup4P</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Zhao, Piming</creator><creator>Aguilar, Ana E.</creator><creator>Lee, Joanna Y.</creator><creator>Paul, Lucy A.</creator><creator>Suh, Jung H.</creator><creator>Puri, Latika</creator><creator>Zhang, Meng</creator><creator>Beckstead, Jennifer</creator><creator>Witkowski, Andrzej</creator><creator>Ryan, Robert O.</creator><creator>Saba, Julie D.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>L.-</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20191201</creationdate><title>Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway</title><author>Zhao, Piming ; Aguilar, Ana E. ; Lee, Joanna Y. ; Paul, Lucy A. ; Suh, Jung H. ; Puri, Latika ; Zhang, Meng ; Beckstead, Jennifer ; Witkowski, Andrzej ; Ryan, Robert O. ; Saba, Julie D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c215w-773c1b96eef564378cc2b6e83aff0895cd435372e73eec90af1f5358e396023a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>AKT protein</topic><topic>Correction</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neuroblastoma</topic><topic>Oncology</topic><topic>Pharmacology/Toxicology</topic><topic>Signal transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Piming</creatorcontrib><creatorcontrib>Aguilar, Ana E.</creatorcontrib><creatorcontrib>Lee, Joanna Y.</creatorcontrib><creatorcontrib>Paul, Lucy A.</creatorcontrib><creatorcontrib>Suh, Jung H.</creatorcontrib><creatorcontrib>Puri, Latika</creatorcontrib><creatorcontrib>Zhang, Meng</creatorcontrib><creatorcontrib>Beckstead, Jennifer</creatorcontrib><creatorcontrib>Witkowski, Andrzej</creatorcontrib><creatorcontrib>Ryan, Robert O.</creatorcontrib><creatorcontrib>Saba, Julie D.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Global</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Investigational new drugs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Piming</au><au>Aguilar, Ana E.</au><au>Lee, Joanna Y.</au><au>Paul, Lucy A.</au><au>Suh, Jung H.</au><au>Puri, Latika</au><au>Zhang, Meng</au><au>Beckstead, Jennifer</au><au>Witkowski, Andrzej</au><au>Ryan, Robert O.</au><au>Saba, Julie D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway</atitle><jtitle>Investigational new drugs</jtitle><stitle>Invest New Drugs</stitle><addtitle>Invest New Drugs</addtitle><date>2019-12-01</date><risdate>2019</risdate><volume>37</volume><issue>6</issue><spage>1309</spage><epage>1309</epage><pages>1309-1309</pages><issn>0167-6997</issn><eissn>1573-0646</eissn><abstract>The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31032525</pmid><doi>10.1007/s10637-019-00772-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-6997 |
| ispartof | Investigational new drugs, 2019-12, Vol.37 (6), p.1309-1309 |
| issn | 0167-6997 1573-0646 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2216769860 |
| source | SpringerLink Journals |
| subjects | AKT protein Correction Medicine Medicine & Public Health Neuroblastoma Oncology Pharmacology/Toxicology Signal transduction |
| title | Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T04%3A30%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction%20to:%20Sphingadienes%20show%20therapeutic%20efficacy%20in%20neuroblastoma%20in%20vitro%20and%20in%20vivo%20by%20targeting%20the%20AKT%20signaling%20pathway&rft.jtitle=Investigational%20new%20drugs&rft.au=Zhao,%20Piming&rft.date=2019-12-01&rft.volume=37&rft.issue=6&rft.spage=1309&rft.epage=1309&rft.pages=1309-1309&rft.issn=0167-6997&rft.eissn=1573-0646&rft_id=info:doi/10.1007/s10637-019-00772-w&rft_dat=%3Cproquest_cross%3E2215984067%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2215984067&rft_id=info:pmid/31032525&rfr_iscdi=true |